Acoltremon

Overview

Acoltremon is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2441929).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Acoltremon expires 16 Dec 2042 and exclusivity 28 May 2030. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide

Canonical SMILES

C[C@@H]1CC[C@H]([C@@H](C1)C(=O)NC2=CC=C(C=C2)OC)C(C)C

InChIKey

HNSGVPAAXJJOPQ-XOKHGSTOSA-N